Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, lipid-lowering drugs, were associated with a 22% lower risk for nonmelanoma skin cancer (NMSC) in patients with atherosclerotic ...

DecisionDx-SCC test predicts local recurrence and metastasis in high-risk cutaneous squamous cell carcinoma, enhancing personalized treatment decisions. The test categorizes patients into three risk ...

WASHINGTON — In 2013, Vishal A. Patel, MD, was completing a fellowship in Mohs surgery and cutaneous oncology at Columbia University Irving Medical Center, New York City, when a study was published ...

Taking nicotinamide—a vitamin B3 derivative sold as an over-the-counter supplement—may help prevent skin cancer. This is the claim of scientists from Vanderbilt University Medical Center who found ...

A major shift is unfolding in the field of skin cancer prevention, ignited by new research showing that an everyday vitamin supplement may prevent many cases of the world’s most frequently diagnosed ...

A health tech company and Dr. Kevin Wong, founder of PT Family Medicine, partner to bring advanced, non-invasive skin cancer evaluation to rural Penn Trafford. MIAMI ...

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...